NCT07786961Not yet recruiting
Music Medicine in Coronary Interventional Cardiology Procedures
Effects of Music Medicine in Patients Undergoing Coronary Interventional Cardiology Procedures
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
The purpose of the study is: to evaluate the effectiveness of a personalized Music Medicine intervention in patients undergoing invasive coronary interventional cardiology procedures. The study will compare patients who listen to a personalized music playlist through wireless earphones throughout the procedure with patients receiving standard care without music. The primary objective is to assess whether Music Medicine reduces state anxiety, measured using the State-Trait Anxiety Inventory (STAI-Y1). Secondary objectives are to evaluate its effects on access-site crossover, procedural pain, blood pressure, heart rate, and oxygen saturation. The study will also assess adverse reactions, withdrawals, patient satisfaction with the intervention, and, in the Music Medicine group, patients' perceived experience through a semi-structured qualitative interview. The study is designed as a prospective, single-center, open-label, randomized controlled trial with two parallel groups and a 1:1 allocation ratio, enrolling 208 participants. The question the study is trying to answer is: whether listening to a personalized music playlist during an invasive coronary interventional cardiology procedure, in addition to standard care, reduces state anxiety compared with standard care alone, and whether it also improves other relevant procedural outcomes, including pain, the need for access-site crossover, blood pressure, heart rate, and oxygen saturation, without interfering with routine clinical care
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 208 (estimated)
- First submitted
- 20 Aug 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 31 Aug 2029
- Lead sponsor
- Azienda Ospedaliero Universitaria di Sassari
- Diseases
- Coronary artery disease
- NCT number
- NCT07786961
What you commit to
- Study type: Interventional
- Planned participants: 208
- From 1 Sept 2026 to the primary completion date, 31 Aug 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- use of antipsychotic medications, assessed through clinical history;
Other illness
- patients with ST-segment elevation myocardial infarction (STEMI);
- patients with very-high-risk non-ST-segment elevation myocardial infarction (NSTEMI), as classified according to the 2023 European Society of Cardiology (ESC) Guidelines;
- presence of hearing impairment or deafness, assessed through clinical history;
- patients with resuscitated cardiac arrest;
- history of epilepsy, assessed through clinical history.
Other
- patients in cardiogenic shock;
- patients unable to express their musical preferences;
Who the study is looking for
- age \>18 years;
- provision of written informed consent and ability to understand the informed consent form.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SS Annunziata Hospital, Sassari Coordinator of this site? Confirm its status | Sassari | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.